(NASDAQ: HYFT) Mindwalk Holdings's forecast annual revenue growth rate of 19.76% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 90.71%, and while it is forecast to beat the US market's average forecast revenue growth rate of 11.87%.
Mindwalk Holdings's revenue in 2025 is $16,244,927.On average, 1 Wall Street analysts forecast HYFT's revenue for 2026 to be $735,696,641, with the lowest HYFT revenue forecast at $735,696,641, and the highest HYFT revenue forecast at $735,696,641. On average, 1 Wall Street analysts forecast HYFT's revenue for 2027 to be $1,025,544,502, with the lowest HYFT revenue forecast at $1,025,544,502, and the highest HYFT revenue forecast at $1,025,544,502.
In 2028, HYFT is forecast to generate $1,282,161,398 in revenue, with the lowest revenue forecast at $1,282,161,398 and the highest revenue forecast at $1,282,161,398.